Imatinib Mesylate Market Insight: Market Trends, Growth, Forecasted from 2024 TO 2031

What is Imatinib Mesylate? Imatinib Mesylate, commonly known by the brand name Gleevec, is a tyrosine kinase inhibitor that has demonstrated significant efficacy in the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (...